Compensation award — excluded from discretionary-purchase analysis.
Traded Jun 10, 2026 · Filed Jun 11, 2026
A board member of Centene Corporation sold $5.16M of Centene Corporation shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$5,164,000
Shares × reported transaction price
43 days after results of Apr 28, 2026, 48 days before results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $65.34 on Jun 10, 2026, within 2% of its 52-week high, after a 32% rise over the previous 30 trading days
52-week range $25.21 (Aug 6, 2025) to $66.21 (Jun 9, 2026), 98% of the way up, from 251 adjusted closes. 30 trading days earlier: $49.57 on Apr 28, 2026. Describes the past only, not a forecast
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Jul 9, 2025 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Lunstrum v. Centene Corporation, docket 1:25-cv-05659, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.3% | +0.4% | -2.7% |
| 30 days | +4.8% | +1.0% | +3.8% |
| 90 days | +0.3% | +2.2% | -1.9% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.